GlassScriptPhysician profile
Isaac Vargas Cesar
NPI 1548276561
$3,511.77
in general payments reported to CMS, 2019-2025
22 companies · $67.29 in 2025
The $67.29 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $362 · 2021: $318 · 2022: $481 · 2023: $1,084 · 2024: $104 · 2025: $67.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $936.26 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $823.58 | 2019-2025 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.40 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $294.31 | 2020-2025 | Mounjaro |
| Amgen INC. | $171.42 | 2023-2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.31 | 2019 | |
| Boston Scientific Corporation | $124.99 | 2019 | |
| Abbvie INC. | $115.53 | 2023 | Qulipta, Ubrelvy |
| Pfizer INC. | $80.29 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $49.86 | 2019-2021 | |
| Exact Sciences Corporation | $46.04 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $43.39 | 2022-2023 | Arexvy |
| Abbott Laboratories | $41.90 | 2023 | Freestyle Libre |
| Mission Pharmacal Company | $32.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.17 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.92 | 2019 | |
| Esperion Therapeutics, INC. | $17.69 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.05 | 2021 | |
| Genentech USA, INC. | $15.64 | 2020 | |
| Medtronic, INC. | $15.25 | 2021 | |
| Redhill Biopharma INC. | $14.67 | 2020 | |
| Phadia US INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Vargas Cesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.